The most frequently used biomarkers to support the diagnosis of Alzheimer’s Disease (AD) are Aβ42, total-Tau, and phospho-tau protein levels in CSF. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.